European Organisation for Research and Treatment of Cancer
EU lobbying footprint — who they meet, and on what. Built only from official disclosures, every meeting cited.
European Organisation for Research and Treatment of Cancer has 19 disclosed EU lobbying meetings from 2020-02-05 to 2026-07-22: 13 with the European Commission and 6 with Members of the European Parliament. Source: EU Transparency Register no. 70539554035-46, Commission disclosures and MEP declarations.
Lobbying profile
as declared 2025-12-04- Category
- Non-governmental organisations, platforms and networks and similar
- Legal status
- AISBL
- Declared lobbying cost
- €0
- Lobbying FTEs
- 0.45
- Members
- 1
Files it’s lobbying on
The org's disclosed policy areas, ranked by number of meetings.
Declared fields of interest
Public health · Research and innovation
At a glance
The officials and MEPs most often met, by disclosed-meeting count.
- Stella Kyriakides3
- Tove Ernst2
- Olivér Várhelyi1
- Karolina Tomaszewska-Boillot1
- Sandra Gallina1
Disclosed meetings
Newest first. EC = European Commission, EP = Member of the European Parliament.
- Brain Cancersource ↗
- Health Policysource ↗
- Intro meetingsource ↗
- 2026-02-17ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiClinical trialssource ↗
- 2026-02-17ECKarolina Tomaszewska-Boillot · Cabinet of Commissioner Olivér VárhelyiClinical trialssource ↗
- 2026-01-28ECSandra Gallina · Director-GeneralEU clinical trials regulationsource ↗
- 2026-01-27ECPatricia Reilly · Cabinet of President Ursula von der LeyenClinical trialssource ↗
- 2026-01-22ECKasia Jurczak · Head of UnitIntroductory meeting with new RTD/D Directorsource ↗
- 2026-01-22ECMaria Pilar Aguar Fernandez · DirectorIntroductory meeting with new RTD/D Directorsource ↗
- 2025-11-06ECMaya Matthews · Head of UnitInvolvement of clinical experts taking part in joint clinical assessments and scientific consultations under the EU Health Technology Assessment (HTA) Regulationsource ↗
- Cancer, public health researchsource ↗
- Politique de santé de l'Union européenne - Optimisation des traitementssource ↗
- Treatment Optimization in Oncologysource ↗
- 2024-06-11ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesMeeting on Europe’s Beating Cancer Plan and EU Policy on cancer; research and treatment optimisationsource ↗
- 2022-03-11ECTove Ernst · Cabinet of Commissioner Stella KyriakidesDiscussion on Europe's Beating Cancer Plan and breast cancersource ↗
- 2021-02-24ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesExchange of views on Europe’s Beating Cancer Plan, the EU Pharmaceutical Strategy and the availability of medicines.source ↗
- 2020-11-03ECTove Ernst · Cabinet of Commissioner Stella KyriakidesExchange of views on Europe’s Beating Cancer Plansource ↗
- 2020-02-19ECAnne Bucher · Director-Generalchallenges of documenting robust evidence for the use of cancer treatmentssource ↗
- 2020-02-05ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesDiscussion on Cancer and Europe's Beating Cancer Plansource ↗
Frequently asked
How many EU lobbying meetings has European Organisation for Research and Treatment of Cancer disclosed?
European Organisation for Research and Treatment of Cancer (EU Transparency Register no. 70539554035-46) appears in 19 disclosed meetings with EU officials and MEPs between 2020-02-05 and 2026-07-22: 13 with the European Commission and 6 with Members of the European Parliament.
What does European Organisation for Research and Treatment of Cancer lobby on?
European Organisation for Research and Treatment of Cancer's disclosed EU meetings most often concern Technology, Health. Every meeting and its topic is listed with its official source on this page.
Who does European Organisation for Research and Treatment of Cancer meet in Brussels?
Across its disclosed meetings, European Organisation for Research and Treatment of Cancer has met Commission officials including Stella Kyriakides, Tove Ernst, Olivér Várhelyi, and MEPs including WILMÈS Sophie, SOKOL Tomislav, VASILE-VOICULESCU Vlad. These are counts of officially disclosed meetings, not a measure of influence.
Primary sources
Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.
Related on the graph
The same footprint, mapped onto the topics and files it touches.
Get the EU lobbying brief
We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.
See your company’s overlap with European Organisation for Research and Treatment of Cancer — and the rest of the corpus.
Enter your company and Lex builds a cited Exposure Map in about 30 seconds. Free, no login.